Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults

This study has been completed.

Sponsor:

Collaborator:

GlaxoSmithKline

Information provided by:

U.S. Army Medical Research and Materiel Command

ClinicalTrials.gov Identifier:

NCT01290601

First received: February 3, 2011

Last updated: NA

Last verified: February 2011

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2005
Primary Completion Date:	January 2005 (Final data collection date for primary outcome measure)